Payoneer Global Inc vs Personalis Inc. Common Stock — how do they compare? Payoneer Global Inc trades at $7.12 (market cap $2.42B), while Personalis Inc. Common Stock trades at $16.14 (market cap $1.70B). The key difference: Payoneer Global Inc is the larger of the two by market cap, and Payoneer Global Inc is trading nearer its 52-week high, Personalis Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Payoneer Global Inc for 62 Days and Personalis Inc. Common Stock for 0 Days on average.
| PAYO | PSNL | |
|---|---|---|
Market Cap | $2.42B | $1.70B |
Volume | 1,987,307 | 3,262,398 |
Sector | Technology | Health |
52-Week High | $7.18 | $18.38 |
52-Week Low | $4.27 | $5.04 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $2.16B | $1.52B |
Signals from Pluang's Aura AI — not financial advice
Payoneer Global (PAYO) trades at $7.15, up 0.42% with mixed technical signals showing a bullish overall trend but bearish moving averages. The company reported Q2 2026 earnings of $0.02 per share, missing estimates, while revenue grew 10% excluding interest. Recent developments include the renewal of its Etsy partnership through 2029 and the announcement of a pending acquisition by Nuvei, creating significant investor interest and legal scrutiny.
The outlook remains cautiously optimistic with 60% analyst buy ratings, though earnings volatility and the pending acquisition create uncertainty. Key opportunities include strong B2B growth acceleration (48% YoY) and expanding international presence, while risks involve integration challenges with Nuvei and margin compression as net income margins decline from 16.8% in 2024 to 5.82% projected for 2026.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →